In the United States, nearly half of all adults (56 million or 48.6%) over 40 years of age have blood cholesterol levels that put them at risk for atherosclerotic cardiovascular disease (ASCVD), increasing the possibility ...
Jul 19, 2021
0
1
Individuals with genetic high cholesterol, heart disease, or both and who were infected with COVID-19 had more heart attacks according to new research by the FH Foundation. While previous studies have speculated about poorer ...
May 27, 2021
0
3
Atherosclerosis—hardening of the arteries—is now involved in the majority of deaths worldwide, and advances in our understanding of the biology of the disease are changing traditional views and opening up new avenues ...
Apr 21, 2021
1
16
I have high cholesterol, but I can't take statin drugs. Are there any new medications that I should consider?
Feb 16, 2021
0
4
Recreational drinking, smoking, and drug use is linked to premature heart disease in young people, particularly younger women, finds research published online in the journal Heart.
Feb 15, 2021
0
49
Children born with a common genetic condition, familial hypercholesterolemia (FH), are at increased risk for atherosclerotic cardiovascular disease (ASCVD) early in life. Despite long-standing national guidelines, cholesterol ...
Nov 18, 2020
0
2
The standard approach of assessing long-term risk for atherosclerotic cardiovascular disease (ASCVD) works just as well for patients who are overweight as they do for patients at an optimal weight, according to a new study ...
Nov 10, 2020
0
8
In a clinical trial testing two different forms of "nudging," statin prescriptions at the right dosages increased significantly among patients with heart disease when doctors had to actively choose whether or not to prescribe ...
Oct 7, 2020
0
3
(HealthDay)—More than 12 percent of patients with atherosclerotic cardiovascular disease (ASCVD) report nonadherence to medications due to costs, according to a study published online Nov. 25 in Circulation.
Nov 27, 2019
0
1
Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum ...
Nov 18, 2019
0
10
